How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gile...

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical trial operations while working to develop lifesaving interventions. At Gilead Sciences, this need to quickly pivot led to an increase...

Enterprise data strategy: Is your healthcare organization equipped to manage and execute in today’s world?

By: John Cappiello, HealthVerity CTO The healthcare landscape is changing and the need for an enterprise-wide data strategy is no longer just a “nice-to-have”. Today’s healthcare enterprises recognize that achieving a comprehensive view of all patien...

Enterprise data strategy: Is your healthcare organization equipped to manage and execute in today’s ...

By: John Cappiello, HealthVerity CTO The healthcare landscape is changing and the need for an enterprise-wide data strat...

JPM19: Takeaways from pharma’s “must-attend” event

We left San Francisco after a highly successful and transformative week for HealthVerity and yet didn’t attend one sessi...

Subscribe to the HealthVerity blog